MapLight Therapeutics, Inc. Common Stock (MPLT) is a publicly traded the market company. As of May 21, 2026, MPLT trades at $27.75 with a market cap of $1.20B and a P/E ratio of -1.47. MPLT moved +2.99% today. Year to date, MPLT is +61.50%; over the trailing twelve months it is flat. Its 52-week range spans $12.24 to $33.28. Analyst consensus is strong buy with an average price target of $38.26. Rallies surfaces MPLT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MapLight Therapeutics, Inc. Common Stock (MPLT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MPLT moved +2.99% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $27.75 |
| Market Cap | $1.20B |
| P/E Ratio | -1.47 |
| EPS | $-18.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.28 |
| 52-Week Low | $12.24 |
| Volume | 174.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-161.15M |
| Gross Margin | 0.00% |
6 analysts cover MPLT: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $38.26.